Kevin Stefanski
Impact in
- Pharmaceutical Science top 0.5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Urology top 10%
- Hair Growth and Disorders
Papers in
-
- Drug Solubulity and Delivery Systems 7
- Advancements in Transdermal Drug Delivery 4
- Advanced Drug Delivery Systems 3
- Co-authors
- Michael J. Hageman (6 shared papers)Feng Qian (4 shared papers)Munir Hussain (5 shared papers)Roy Haskell (4 shared papers)Ching Su (5 shared papers)Yuejie Chen (3 shared papers)Ping Gao (1 shared paper)Tiehua Huang (1 shared paper)
- Journals
- Journal of Pharmaceutical Sciences (3 papers)Molecular Pharmaceutics (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Pharmaceutical Research (2 papers)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Kevin Stefanski
16 papers receiving 713 citations
Peers
Comparison fields: 5 of 85
- Pharmaceutical Science 502
- Urology 48
- Analytical Chemistry 81
- Spectroscopy 99
- Drug Discovery 1
Countries citing papers authored by Kevin Stefanski
This map shows the geographic impact of Kevin Stefanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Stefanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Stefanski more than expected).
Fields of papers citing papers by Kevin Stefanski
This network shows the impact of papers produced by Kevin Stefanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Stefanski. The network helps show where Kevin Stefanski may publish in the future.
Co-authors
The 25 scholars most cited alongside Kevin Stefanski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 179 | |
| 2 | 2014 | 153 | |
| 3 | 2016 | 107 | |
| 4 | 1992 | 69 | |
| 5 | 2016 | 67 | |
| 6 | 2017 | 63 | |
| 7 | 1996 | 50 | |
| 8 | 2014 | 14 | |
| 9 | 2016 | 12 | |
| 10 | 2007 | 8 | |
| 11 | 2018 | 8 | |
| 12 | 2022 | 6 | |
| 13 | 2021 | 4 | |
| 14 | 2021 | 3 | |
| 15 | 2016 | 3 | |
| 16 | 2016 | 1 |
About Kevin Stefanski
Kevin Stefanski is a scholar working on Pharmaceutical Science, Infectious Diseases, Molecular Biology, Pediatrics, Perinatology and Child Health and Oncology, having authored 16 papers that have together received 747 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (7 papers), Advancements in Transdermal Drug Delivery (4 papers), Advanced Drug Delivery Systems (3 papers), Graphene and Nanomaterials Applications (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Analytical Methods in Pharmaceuticals (2 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Pharmaceutical Science (502 citations), Urology (48 citations), Analytical Chemistry (81 citations), Spectroscopy (99 citations) and Drug Discovery (1 citation). Kevin Stefanski has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Michael J. Hageman, Feng Qian, Munir Hussain, Roy Haskell, Ching Su, Yuejie Chen, Ping Gao, Tiehua Huang, Qun Lu and Chengyu Liu. Their work appears in journals such as Journal of Pharmaceutical Sciences, Molecular Pharmaceutics, Bioorganic & Medicinal Chemistry Letters, Pharmaceutical Research and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.